Precision Optics (OTCMKTS:PEYE) versus NxStage Medical (OTCMKTS:NXTM) Financial Contrast

Precision Optics (OTCMKTS:PEYE) and NxStage Medical (NASDAQ:NXTM) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Valuation and Earnings

This table compares Precision Optics and NxStage Medical’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Precision Optics $4.04 million 3.44 -$350,000.00 N/A N/A
NxStage Medical $393.94 million 5.08 -$14.47 million ($0.22) -136.36

Precision Optics has higher earnings, but lower revenue than NxStage Medical.

Risk & Volatility

Precision Optics has a beta of 1.93, indicating that its share price is 93% more volatile than the S&P 500. Comparatively, NxStage Medical has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500.

Profitability

This table compares Precision Optics and NxStage Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Precision Optics -8.31% -2.05% -1.01%
NxStage Medical -1.29% -2.50% -1.60%

Insider & Institutional Ownership

80.3% of NxStage Medical shares are owned by institutional investors. 24.7% of Precision Optics shares are owned by insiders. Comparatively, 4.9% of NxStage Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and price targets for Precision Optics and NxStage Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics 0 0 0 0 N/A
NxStage Medical 0 0 0 0 N/A

Summary

Precision Optics beats NxStage Medical on 5 of the 9 factors compared between the two stocks.

Precision Optics Company Profile

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies, which are designed for industrial and military use. The company markets its products to original equipment manufacturers through medical device companies. Precision Optics Corporation, Inc. has collaboration with OmniVision Technologies, Inc. to develop optical solutions based on an image sensor integrated with its lenses. The company was founded in 1982 and is based in Gardner, Massachusetts.

NxStage Medical Company Profile

NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home and critical care market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. As of February 3, 2018, it had 21 centers. NxStage Medical, Inc. markets its products through direct sales to dialysis clinics and hospitals in the United States, the United Kingdom, and Canada, as well as through distributors in Europe and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.

Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit